With MYPG, you can obtain the unique genetic information about your cancer in order to make informed decisions. These results enable your healthcare team to create a personalized treatment plan based on the most up to date therapies and clinical trials.Cancer is a genetic disease driven by mutations in genes that convert normal cells into cancer cells. Normally, the genes within a cell serve as the instruction manual for how the cell behaves and performs. In cancer, mutations within key genes cause uncontrollable growth and invasion. MYPG sequences the most important cancer genes for mutations that may provide the insight needed to best manage your cancer.
Information about particular genes in your tumor cells and how they are different from normal cells can help physicians create a more personalized treatment plan for you.The results from the test may provide more insight into cancer therapy, disease classification, or prognosis. Ongoing clinical trials that target your cancer may be identified.
Personal Genome Diagnostics offers tests to identify specific information about your tumor and its genetic makeup.
Who is eligible
What we need
CancerSELECT™: After the raw data is converted to DNA sequences, the tumor and normal data are compared, which allows for the detection of tumor-specific alterations, as well as quality control metrics across the targeted region.PlasmaSELECT™ 64: Tumor-specific mutations, copy number changes, and rearrangements are identified and annotated using proprietary PGDx algorithms.
The tumor-specific mutations are identified, including sequence alterations, small insertions and deletions, copy number alterations and rearrangements.Tumor-specific mutations, copy number changes, and rearrangements are identified and annotated using proprietary PGDx algorithms.
Making sense of your cancer genome:All documented mutations will then be linked to clinical and biological information which may indicate how a particular tumor may respond to therapy, permit enrollment into an ongoing clinical trial, and provide other clinical and biologic aspects important in your tumor. Optional clinical trial enrollment support is available through our partner, Cure Forward.
A list of possible treatment options specific for the genetic alterations found in your tumor.These treatment options may include: • Clinical trials enrolling patients with your genetic alteration and tumor type • Therapies that are approved in your cancer type • Therapies that are approved in other cancer types
The PASS (PGDx Access Support Services) financial assistance program offers discounts to patients in compliance with US Department of Health and Human Services guidelines.
Eligibility is based on family size and income level.
Tiered discounts are available up to 100%.
To check your eligibility, submit an application form.
Call us at 888-571-2163
or see below.